Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 3 of 3 entries
Sorted by: Best Match Show Resources per page
Prognostic Significance of the Labeling of Adnab-9 in Pancreatic Intraductal Papillary Mucinous Neoplasms.

International journal of gastrointestinal cancer

Tobi M, Hatfield J, Adsay V, Galagan K, Kozarek R, Inagaki M, Kasai S, Tokusashi Y, Obara T, Hruban R, Lough J, Barkun A, Jabbari M, Sheikh R, Ruebner B, Lawson M, Ben-Josef E, Fligiel S.
PMID: 12754384
Int J Gastrointest Cancer. 2001;29(3):141-150.

First described as a distinct entity in the early1980s (1), pancreatic ductal neoplasms with mucinhypersecretion have been increasingly recognized.This motivated the World Health Organization(WHO) reclassification proposal in 1996 (2), which separated them from mucinous cystic neoplasms.These tumors are now...

Cite
Tobi M, Hatfield J, Adsay V, et al. Prognostic Significance of the Labeling of Adnab-9 in Pancreatic Intraductal Papillary Mucinous Neoplasms. Int J Gastrointest Cancer. 2001;29(3):141-150
Tobi, M., Hatfield, J., Adsay, V., Galagan, K., Kozarek, R., Inagaki, M., Kasai, S., Tokusashi, Y., Obara, T., Hruban, R., Lough, J., Barkun, A., Jabbari, M., Sheikh, R., Ruebner, B., Lawson, M., Ben-Josef, E., & Fligiel, S. (2001). Prognostic Significance of the Labeling of Adnab-9 in Pancreatic Intraductal Papillary Mucinous Neoplasms. International journal of gastrointestinal cancer, 29(3), 141-150.
Tobi, Martin, et al. "Prognostic Significance of the Labeling of Adnab-9 in Pancreatic Intraductal Papillary Mucinous Neoplasms." International journal of gastrointestinal cancer vol. 29,3 (2001): 141-150.
Tobi M, Hatfield J, Adsay V, Galagan K, Kozarek R, Inagaki M, Kasai S, Tokusashi Y, Obara T, Hruban R, Lough J, Barkun A, Jabbari M, Sheikh R, Ruebner B, Lawson M, Ben-Josef E, Fligiel S. Prognostic Significance of the Labeling of Adnab-9 in Pancreatic Intraductal Papillary Mucinous Neoplasms. Int J Gastrointest Cancer. 2001;29(3):141-150. PMID: 12754384.
Copy Download .nbib Format: NLM
Substrate-dependent differences in production of extracellular matrix molecules by squamous carcinoma cells and diploid fibroblasts.

Biotechnology and bioengineering

Varani J, Fligiel SE, Inman DR, Helmreich DL, Bendelow MJ, Hillegas W.
PMID: 18587855
Biotechnol Bioeng. 1989 Apr 20;33(10):1235-41. doi: 10.1002/bit.260331003.

Two human squamous carcinoma cell lines and human diploid fibroblasts were examined for the production of extracellular matrix (ECM) molecules including fibronectin (FN), laminin (LN), and thrombospondin (TSP) when grown on a number of different substrates. The substrates used...

Cite
Varani J, Fligiel SE, Inman DR, et al. Substrate-dependent differences in production of extracellular matrix molecules by squamous carcinoma cells and diploid fibroblasts. Biotechnol Bioeng. 1989;33(10):1235-41doi: 10.1002/bit.260331003.
Varani, J., Fligiel, S. E., Inman, D. R., Helmreich, D. L., Bendelow, M. J., & Hillegas, W. (1989). Substrate-dependent differences in production of extracellular matrix molecules by squamous carcinoma cells and diploid fibroblasts. Biotechnology and bioengineering, 33(10), 1235-41. https://doi.org/10.1002/bit.260331003
Varani, J, et al. "Substrate-dependent differences in production of extracellular matrix molecules by squamous carcinoma cells and diploid fibroblasts." Biotechnology and bioengineering vol. 33,10 (1989): 1235-41. doi: https://doi.org/10.1002/bit.260331003
Varani J, Fligiel SE, Inman DR, Helmreich DL, Bendelow MJ, Hillegas W. Substrate-dependent differences in production of extracellular matrix molecules by squamous carcinoma cells and diploid fibroblasts. Biotechnol Bioeng. 1989 Apr 20;33(10):1235-41. doi: 10.1002/bit.260331003. PMID: 18587855.
Copy Download .nbib Format: NLM
A Novel Calcium-Mediated EMT Pathway Controlled by Lipids: An Opportunity for Prostate Cancer Adjuvant Therapy.

Cancers

Figiel S, Bery F, Chantôme A, Fontaine D, Pasqualin C, Maupoil V, Domingo I, Guibon R, Bruyère F, Potier-Cartereau M, Vandier C, Fromont G, Mahéo K.
PMID: 31752242
Cancers (Basel). 2019 Nov 18;11(11). doi: 10.3390/cancers11111814.

The composition of periprostatic adipose tissue (PPAT) has been shown to play a role in prostate cancer (PCa) progression. We recently reported an inverse association between PCa aggressiveness and elevated PPAT linoleic acid (LA) and eicosapentaenoic acid (EPA) content....

Cite
Figiel S, Bery F, Chantôme A, et al. A Novel Calcium-Mediated EMT Pathway Controlled by Lipids: An Opportunity for Prostate Cancer Adjuvant Therapy. Cancers (Basel). 2019;11(11)doi: 10.3390/cancers11111814.
Figiel, S., Bery, F., Chantôme, A., Fontaine, D., Pasqualin, C., Maupoil, V., Domingo, I., Guibon, R., Bruyère, F., Potier-Cartereau, M., Vandier, C., Fromont, G., & Mahéo, K. (2019). A Novel Calcium-Mediated EMT Pathway Controlled by Lipids: An Opportunity for Prostate Cancer Adjuvant Therapy. Cancers, 11(11), . https://doi.org/10.3390/cancers11111814
Figiel, Sandy, et al. "A Novel Calcium-Mediated EMT Pathway Controlled by Lipids: An Opportunity for Prostate Cancer Adjuvant Therapy." Cancers vol. 11,11 (2019). doi: https://doi.org/10.3390/cancers11111814
Figiel S, Bery F, Chantôme A, Fontaine D, Pasqualin C, Maupoil V, Domingo I, Guibon R, Bruyère F, Potier-Cartereau M, Vandier C, Fromont G, Mahéo K. A Novel Calcium-Mediated EMT Pathway Controlled by Lipids: An Opportunity for Prostate Cancer Adjuvant Therapy. Cancers (Basel). 2019 Nov 18;11(11). doi: 10.3390/cancers11111814. PMID: 31752242; PMCID: PMC6896176.
Copy Download .nbib Format: NLM
Showing 1 to 3 of 3 entries